presented with blurring and transient obscuration of vision with papilledema, headache, tinnitus, and vomiting. On magnetic resonance venography and digital subtraction angiography, chronic transverse sinus thrombosis was diagnosed for which patients underwent endovascular intervention (stenting). After the resolution of CVST, patients developed the recurrence of symptoms which on digital subtraction angiography revealed dural arteriovenous malformation (DAVM). DAVM and papilledema resolved with endovascular embolization. This case series highlights a need of constant monitoring of CVST cases after the endovascular intervention.
Key words: Cerebral venous sinus thrombosis, dural arteriovenous malformation, endovascular, glue embolization, stenting Cerebral venous sinus thrombosis (CVST) may develop a rare and chronic complications such as dural arteriovenous malformation (DAVM). [1] Two-fifths of the patients with DAVM had been found to be associated with CVST in an earlier study involving 69 patients. [2] DAVM may be completely asymptomatic or may present with mild symptoms to fatal cerebral hemorrhage. [3] In the earlier case reports, DAVM after CVST presented with varied symptoms such as a headache, tinnitus, aphasia, seizure, irritability, hemiparesis, and depending on the location. [4] [5] [6] Cases presenting with ophthalmic symptoms leading to the diagnosis of DAVM have been reported rarely. [7] This is a first case series reporting the cases of the transverse sinus (TS) thrombosis who after successful endovascular stenting showed the recurrence of papilledema and visual loss which on further evaluation led to the diagnosis of DAVM.
Case Reports

Case 1
A 48-year-old male patient presented with the blurring of vision, with a headache, and tinnitus for the past 1 month. Best-corrected visual acuity (BCVA) was 6/6 both eyes. Fundus showed florid papilledema both eyes [ Fig. 1a and b]. Visual fields showed the enlargement of a blind spot. Optical coherence tomography (OCT) showed marked thickening of retinal nerve fiber layer (RNFL). Magnetic resonance venography (MRV) revealed thrombosis of the right TS with partial thrombosis of the superior sagittal sinus. The patient was positive for antiphospholipid antibodies. After starting medical treatment (acetazolamide, furosemide, and glycerine) for raised intracranial pressure with anticoagulant, the papilledema improved minimally. After 2 months, vision deteriorated to 6/60 and 6/9 in the right and left eye, respectively, with persistent papilledema. Digital subtraction angiography (DSA) revealed chronic right TS thrombosis with narrowing of lumen [ Fig Fig. 1c ]. OCT showed the resolution of thickened RNFL.
On the recurrence of a headache, diminished vision and papilledema after 3 months, DSA showed the patent stent with DAVM near right TS [ Fig. 2d ]. On glue embolization of DAVM [ Fig. 2e ], papilledema resolved in both eyes. On the last follow-up of 5 years, patient is asymptomatic.
Case 2
A 26-year-old male patient presented with transient obscuration of vision with tinnitus for 1 year and diminution of vision for 2 months. BCVA was 6/60 and 6/9 in the right and left eye, respectively. Examination revealed relative afferent pupillary defect, secondary optic atrophy in the right eye and full-blown papilledema left eye. Bruit was heard behind the right ear. MRV revealed chronic thrombosis with narrowing of the lumen of right TS. He was advised endovascular angioplasty of the sinus, but patient deferred that treatment. After 6 months, the patient presented with further decrease of vision with papilledema, DSA demonstrated right TS thrombosis with DAVM. Angioplasty and stenting of stenosed TS was performed, but no significant improvement in fundus was noticed. Hence, DAVM was embolized with coils and onyx. Postembolization of DAVM symptoms and papilledema improved with no further deterioration of vision. On follow-up 
Case 3
A 48-year-old female patient presented with a headache, vomiting for 1 month, and diminution of vision for 1 year which deteriorated recently. On examination, BCVA of 6/36 right eye and 6/24 left eye with chronic papilledema was noted. MRV showed chronic right TS thrombosis with partial recanalization. DSA confirmed the MRV findings. She underwent balloon dilatation with stenting of right TS. Following that, vision improved (6/18 both eyes) with the resolution of papilledema. After 6 months, she had the recurrence of symptoms and papilledema. DSA showed a DAVM near right TS which resolved on glue embolization. On follow-up of 4 years, the patient is asymptomatic with the vision of 6/18 both eyes.
Case 4
A 35-year old female patient who had undergone stenting for right TS thrombosis outside presented with right-sided headache, transient obscuration of vision and tinnitus for 4 months. On examination, BCVA of 6/18 both eyes with chronic papilledema was noticed. DSA indicated DAVM near left TS [ Fig. 3a ] with enlarged cortical veins with partially thrombosed sinuses [ Fig. 3b ] which was embolized with coils and glue [ Fig. 3c ]. After embolization, DAVM resolved [ Fig. 3d ]. The patient is asymptomatic with stable vision on follow-up of 5 years.
Discussion
After a successful endovascular intervention of CVST, occasionally patient may develop DAVM. Houser et al. first reported the development of DAVM in patients with CVST. [8] DAVMs are acquired vascular malformations formed between meningeal arteries and dural veins. The exact mechanism for the genesis of DAVM in patients with CVST is not known but likely to involve multiple factors. It has been proposed that DAVM arises from venous hypertension leading to low perfusion pressure and subsequent cerebral ischemia further leading to the release of angiogenic factors such as vascular endothelial growth factor with subsequent formation of abnormal connections between arteries and venous sinuses. [9] Patients with DAVM may present with ophthalmic features such as the blurring of vision, transient obscuration of vision, rapid fall of vision, and papilledema. In an earlier case report, Houser et al. reported a patient of DAVM presenting with blurred vision, headache, low back pain, and slurred speech after 3 years of TS thrombosis. [10] Another case of DAVM presenting with ophthalmic features developing 1 year after treatment of CVST reported by Micieli et al. recently. [7] Similarly, our cases of CVST presented with various ophthalmic features with symptoms of raised intracranial pressure which resolved after endovascular management. We reported the reappearance of papilledema associated with a headache and blurring of vision associated with raised intracranial pressure which pointed toward the new appearance of vascular thrombosis or a dural malformation such as DAVM which was confirmed on DSA.
OCT was an effective tool to document the RNFL thickening in papilledema and monitor the treatment response in the follow-up period similarly used by Micieli et al. [7] 
Conclusion
After successful management of CVST, continuous monitoring including ophthalmic evaluation is highly required as these patients may develop rare complications such as DAVM which may further lead to a visual and neurological deficit.
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Ultrasound B-scan showed the absence of the optic nerve shadow in the right eye. Computerized tomography imaging of the brain and orbit at the level of the optic nerve showed enophthalmos of the right eye. The anterior segment of the right optic nerve in its intraorbital course was absent, posterior segment appeared as a thin cord. No significant anomaly of the brain was noted. T1 weighted, coronal magnetic resonance imaging (MRI) revealed complete absence of the optic nerve in the right eye in the expected location in the intraconal fat, thus confirming the absence of the orbital part of the optic nerve [ Fig. 2 ].
Case 2
A 5-year-old child with unremarkable birth history was brought in with the complaints of having no vision in the left eye which appeared small in size since birth. There was a past history of trauma with stone and ocular surgery in the right eye. On examination, best-corrected visual acuity in the right eye was 20/40 with Cardiff cards and no perception of light in the left eye. Right eye showed linear macular corneal scar at 11 o' clock limbus. Iris tissue was deficient from 9 to 11 o'clock hours and the pupil was irregular. Lens was clear and fundus examination was within normal limits. Left eye corneal diameter was 12 mm vertically and 9 mm horizontally. There was partial aniridia from 7 to 2 o' clock hours [ Fig. 3 ]. Fundus examination revealed the complete absence of the optic nerve and retinal vessels and areas of chorioretinal atrophy in the macula and mid-peripheral retina.
Optic nerve aplasia: A case series
K Samyukta Sadasivan, Neelam Pawar, Meenakshi Ravindran, Ramakrishnan Rengappa 1
Optic nerve aplasia (ONA) is a congenital optic nerve anomaly characterized by the absence of optic nerve head, retinal blood vessels, retinal ganglion cells, and optic nerve fibers in a malformed eye. Clinically, the condition presents with the absence of perception of light, afferent pupillary defect and a fundus appearance of absent optic nerve head, and retinal vessels with associated ocular and nonocular abnormalities. Systemic anomalies have been reported with bilateral ONA, whereas unilateral ONA is seen in otherwise healthy individuals. We report three cases of ONA with varied clinical presentations.
Key words: Aplasia of optic nerve, central nervous system anomaly, congenital optic nerve anomaly Optic nerve aplasia (ONA) is a rare, nonhereditary developmental anomaly characterized by congenital absence of the optic nerve, retinal blood vessels, retinal ganglion cells, and optic nerve fibers in a blind eye causing lifelong visual handicap. Unilateral ONA is generally associated with otherwise normal brain development, whereas bilateral ONA is accompanied by central nervous system (CNS) malformations [1] though variations may exist. Ocular or nonocular abnormalities may coexist. Herein, we report three cases of ONA with varied clinical presentations.
